fundvisualizer.com

Janus Henderson Contrarian TJSVAX

Performance (before sales charge)

As of 04/30/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 03/31/2023
Stock
93.25%
Non-U.S. Stock
2.68%
Bond
1.49%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
2.58%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 03/31/2023

Basic materials

6.07%

Consumer cyclical

18.31%

Financial services

7.16%

Real estate

2.81%

Consumer defensive

2.99%

Health care

19.99%

Utilities

4.69%

Communication services

3.17%

Energy

4.23%

Industrials

8.22%

Technology

15.61%

Top 10 holdings

As of 03/31/2023

Caesars Entertainment Inc
5.86%
Howmet Aerospace Inc
5.42%
Crown Holdings Inc
5.37%
Occidental Petroleum Corp
4.23%
Advanced Micro Devices Inc
4.05%
Freeport-McMoRan Inc
3.24%
AbbVie Inc
3.19%
Workday Inc Class A
3.16%
Amazon.com Inc
3.13%
Marvell Technology Inc
3.13%
Fund assets

$4.37 Billion

Share class

Other

Morningstar category

Mid-Cap Blend

Expense ratio

0.98%

Investment objective

Growth

Documents